Skip to main content

Table 4 Indication, use and assessment of aminoglycosides in patients with S. aureus IE (infective endocarditis) according to methicillin susceptibility

From: Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission

  IE due to MSSA (n = 17) IE due to MRSA (n = 9) p
Indication of aminoglycosides 15 (88.2) 9 (100) = 0.28
Delivery of aminoglycosides 14 (82.3) 4 (44.4) <  0.05
Use of aminoglycosides in patients with indication 12 (70.6) 4 (44.4) = 0.18
Aminoglycosides conformity 12 (70.6) 4 (44.4) = 0.18
Number of deaths 2 (11.8) 3 (33.3) = 0.18
  1. Data are presented as No (%)
  2. MSSA methicillin-susceptible S. aureus
  3. MRSA methicillin-resistant S. aureus